Residiv og overlevelse etter brystbevarende behandling av brystkreft

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 4, 2010, Pages 370-374

  Mjaaland, Ingvil ^a   Segers, Ron M P ^b   Dybvik, Kjell Ivar ^b   Bjerkeset, Ottar ^b   Kvaløy, Jan Terje ^b,c   Heikkilä, Reino ^b,d  

^a Stavanger universitetssjukehus   (Norway)

^b Klinikk for blod og kreftsykdommer ^*  (Norway)

^c UNIVERSITY OF STAVANGER   (Norway)

^d Roche Norge   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; NEOPLASM; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77949895368     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.0484     Document Type: Article

References (26)

1. Kreftregisteret. Kreft i Norge 2007 - insidens, overlevelse og prevalens i Norge 2008. Oslo: Kreftregisteret, 2008.
2. NIH consensus conference. Treatment of earlystage breast cancer. JAMA 1991; 265: 391-5.
3. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
4. Veronesi U, Cascinelli N, Mariani L et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
5. Blichert-Toft M, Nielsen M, During M et al. Longterm results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008; 47: 672-81.
6. Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
7. Liljegren G, Holmberg L, Bergh J et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999; 17: 2326-33.
8. Forrest AP, Stewart HJ, Everington D et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996; 348: 708-13.
9. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378-87.
10. Pass H, Vicini FA, Kestin LL et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 2004; 101: 713-20.
11. Cabioglu N, Hunt KK, Buchholz TA et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 2005; 104: 20-9.
12. Nguyen PL, Taghian AG, Katz MS et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008; 26: 2373-8.
13. van Dongen JA, Voogd AC, Fentiman IS et al. Longterm results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000; 92: 1143-50.
14. Mjaaland I, Dybvik KI, Heikkil R et al. Strålebehandling etter brystbevarende kirurgi. Tidsskr Nor Lægeforen 2003; 123: 1683-4.
15. Lonning PE, Geisler J, Krag LE et al. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 2005; 23: 5126-37.
16. The R Project for Statistical Computing. (www.r-project.org) (6.1.2010).
17. Mannino M, Yarnold JR. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld? Radiother Oncol 2009; 90: 14-22.
18. Bartelink H, Horiot JC, Poortmans PM et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-65.
19. Bentzen SM, Agrawal RK, Aird EG et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371: 1098-107.
20. Fisher B, Bryant J, Dignam JJ et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20: 4141-9.
21. Potter R, Gnant M, Kwasny W et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 2007; 68: 334-40.
22. Fyles AW, McCready DR, Manchul LA et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351: 963-70.
23. Hughes KS, Schnaper LA, Berry D et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004; 351: 971-7.
24. Antonini N, Jones H, Horiot JC et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007; 82: 265-71.
25. Kåresen R. Brystkreft. Tidsskr Nor Lægeforen 1997; 117: 3763-4.
26. Kyndi M, Sorensen FB, Knudsen H et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in highrisk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 2008; 26: 1419-26.